Literature DB >> 2509514

Pseudomonas aeruginosa ATCC 49189, a new quality control strain for testing P. aeruginosa susceptibility to the aminoglycosides.

R T Lally1, B F Woolfrey, M A Enright.   

Abstract

Quality control for in vitro antimicrobial susceptibility testing of Pseudomonas aeruginosa versus aminoglycosides is improved by P. aeruginosa ATCC 49189, which was developed in the Clinical Microbiology Laboratory at St. Paul-Ramsey Medical Center. This strain, used by us for daily testing for the past 6 years, requires MICs that approximate therapeutic concentrations, are midrange in most dilution schemes, and are stable and reproducible.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2509514      PMCID： PMC267088          DOI： 10.1128/jcm.27.11.2616-2618.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  6 in total

1.  Comparative evaluation of the micro-media system, sceptor, and MIC-2000 microdilution methods for testing Pseudomonas aeruginosa against gentamicin, tobramycin, and amikacin.

Authors:  B F Woolfrey; R T Lally; C O Quall
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

2.  Evaluation of the automicrobic system for susceptibility testing of Pseudomonas aeruginosa to gentamicin, tobramycin, and amikacin.

Authors:  B F Woolfrey; R T Lally; M N Ederer; C O Quall
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

3.  Broth microdilution testing of Pseudomonas aeruginosa and aminoglycosides: need for employing dilutions differing by small arithmetic increments.

Authors:  B F Woolfrey; J M Fox; R T Lally; C O Quall
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

4.  Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories.

Authors:  A L Barry; C Thornsberry; R N Jones
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

5.  Gentamicin, tobramycin, and sisomicin disc susceptibility tests. Revised zone standards for interpretation.

Authors:  A L Barry; C Thornsberry; R N Jones; E H Gerlach
Journal:  Am J Clin Pathol       Date:  1981-04       Impact factor: 2.493

6.  Comparison of minimum inhibitory concentration values determined by three antimicrobic dilution methods for Pseudomonas aeruginosa.

Authors:  B F Woolfrey; J M Fox; C O Quall
Journal:  Am J Clin Pathol       Date:  1981-01       Impact factor: 2.493
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.